New sedative aims to cut complications and speed up cataract recovery
NCT ID NCT07325227
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study tests whether the sedative remimazolam can reduce complications and shorten recovery time after cataract surgery. Researchers will enroll 30 adults aged 55 to 90 who need surgery on both eyes. The goal is to see if this drug leads to fewer side effects and faster discharge from the recovery room.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple stress ball or favorite tune replace anxiety meds during eye surgery?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- Can trifocal lens implants keep night driving safe and clear?
- Which cataract tool works better? a Head-to-Head test in the same eyes
- Eye scans may forecast lens misalignment after cataract surgery
- Can a stronger eye drop dose shield the retina after cataract surgery?